GCNT2 and urinary bladder cancer: Our results suggest that GCNT2 does not affect integrin-mediated pathways in bladder cancer cells at least, since the expression level of GCNT2 did not affect cell invasiveness or intercellular adhesion, which are likely to be mediated by integrins.